Chinese scientists are celebrating a new breakthrough cancer drug, but some Chinese citizens are skeptical of domestically ...

Private equity fundraising struggled in 2024, with total capital raised declining for the third consecutive year. Read more ...

Why did “ Biotech is in a dark place ” resonate with so many of you? Because it’s true! Collectively, we’re all frustrated ...

Bluebird Bio announced Friday it would sell itself and its portfolio of gene therapies to the investment firms Carlyle and SK ...

Spotlight Therapeutics, a Bay Area biotech startup that aimed to “democratize” CRISPR gene editing for patients, has shut ...

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

Find out about what's behind the increase of securities class action lawsuits in the biotech industry and how to prevent them ...

The biotech industry is on a stable growth path, owing to the integration of modern technologies and rapid drug discoveries.

If this CEO succeeds N-Power could save millions of dollars and lives in the fight against cancer. "The impact for cancer ...

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Joseph Tucker, Chief Executive Officer and Director of Enveric ...

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

The $1.15 billion innovation hub on UC Davis’ Sacramento campus is expected to drive $500 million in annual economic output ...